Recent studies have shown that an increased BRCA gene down-regulation, caused by PI3K protein target inhibition, makes triple-negative breast cancer cells more sensitive to PARP inhibitors, suggesting as PI3K functioning could represent a possible mechanism involved in the occurrence of primary resistance [82, 83]. The gene discussed is PARP1; the disease is triple-negative breast carcinoma.